For Risk-Tolerant Investors, Citius Pharmaceuticals Inc (NASDAQ: CTXR) Stands Out As A Strong Investment Choice
During the recent session, Citius Pharmaceuticals Inc (NASDAQ:CTXR)’s traded shares were 1.16 million, with the beta value of the company hitting 1.55. At the last